Mutation analysis of the SLX4/FANCP gene in hereditary breast cancer

Breast Cancer Research and Treatment

Volumn 130, Issue 3, 2011, Pages 1021-1028

  Landwehr, Rosa ^a   Bogdanova, Natalia V ^a   Antonenkova, Natalia ^b   Meyer, Andreas ^a   Bremer, Michael ^a   Park Simon, Tjoung Won ^a   Hillemanns, Peter ^a   Karstens, Johann H ^a   Schindler, Detlev ^c   Dörk, Thilo ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Research Institute of Oncology and Medical Radiology of the Ministry of Health of the Byelorussian SSR   (Belarus)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Breast cancer susceptibility; Crosslink repair; DNA damage signalling; Fanconi anaemia; Genetic association studies

Indexed keywords

ALANINE; ARGININE; GENOMIC DNA; GLYCINE; HISTIDINE; VALINE;

3' UNTRANSLATED REGION; AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; BYELORUSSIAN; CANCER PATIENT; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; COMPUTER MODEL; CONTROLLED STUDY; DNA FLANKING REGION; ETHNIC GROUP; FAMILIAL CANCER; FANCP GENE; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GERMAN; HAPLOTYPE; HUMAN; HUMAN TISSUE; INHERITANCE; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SLX4 GENE;

ADULT; AGED; BASE SEQUENCE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HAPLOTYPES; HUMANS; MIDDLE AGED; MUTATION; RECOMBINASES; YOUNG ADULT;

EID: 82255175054     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1681-1     Document Type: Article

References (36)

1. S Fekairi S Scaglione C Chahwan ER Taylor A Tissier S Coulon MQ Dong C Ruse JR Yates 3rd P Russell RP Fuchs CH McGowan PH Gaillard 2009 Human SLX4 is a Holliday junction resolvase subunit that binds multiple DNA repair/recombination endonucleases Cell 138 78 89 19596236 10.1016/j.cell.2009. 06.029 1:CAS:528:DC%2BD1MXps1ygur0%3D
2. JM Svendsen A Smogorzewska ME Sowa BC O'Connell SP Gygi SJ Elledge JW Harper 2009 Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair Cell 138 63 77 19596235 10.1016/j.cell.2009.06.030 1:CAS:528:DC%2BD1MXps1ygurw%3D
3. EK Schwartz WD Heyer 2011 Processing of joint molecule intermediates by structure-selective endonucleases during homologous recombination in eukaryotes Chromosoma 120 2 109 127 21369956 10.1007/s00412-010-0304-7 1:CAS:528: DC%2BC3MXjtFGntL0%3D
4. KN Yamamoto S Kobayashi M Tsuda H Kurumizaka M Takata K Kono J Jiricny S Takeda K Hirota 2011 Involvement of SLX4 in interstrand cross-link repair is regulated by the Fanconi anemia pathway Proc Natl Acad Sci USA 108 16 6492 6496 21464321 10.1073/pnas.1018487108 1:CAS:528:DC%2BC3MXlt1amsr0%3D
5. SL Andersen DT Bergstralh KP Kohl JR LaRocque CB Moore J Sekelsky 2009 Drosophila MUS312 and the vertebrate ortholog BTBD12 interact with DNA structures-specific endonucleases in DNA repair and recombination Mol Cell 35 128 135 19595722 10.1016/j.molcel.2009.06.019 1:CAS:528:DC%2BD1MXps1ejsb8%3D
6. IM Muñoz K Hain AC Déclais M Gardiner GW Toh L Sanchez-Pulido JM Heuckmann R Toth T Macartney B Eppink R Kanaar CP Ponting DM Lilley J Rouse 2009 Coordination of structure-specific nucleases by human SLX4/BTBD12 is required for DNA repair Mol Cell 35 116 127 19595721 10.1016/j.molcel.2009.06.020
7. S Flott J Rouse 2005 Slx4 becomes phosphorylated after DNA damage in a Mec1/Tel1-dependent manner and is required for repair of DNA alkylation damage Biochem J 391 325 333 15975089 10.1042/BJ20050768 1:CAS:528:DC%2BD2MXhtFCqsrnE (Pubitemid 41532430)
8. S Matsuoka BA Ballif A Smogorzewska ER McDonald 3rd KE Hurov J Luo CE Bakalarski Z Zhao N Solimini Y Lerenthal Y Shiloh SP Gygi SJ Elledge 2007 ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage Science 316 5828 1160 1166 17525332 10.1126/science.1140321 1:CAS:528:DC%2BD2sXls1Kit7o%3D (Pubitemid 46877472)
9. JK Holloway S Mohan G Balmus X Sun A Modzelewski PL Borst R Freire RS Weiss PE Cohen 2011 Mammalian BTBD12 (SLX4) protects against genomic instability during mammalian spermatogenesis PLoS Genet 7 6 e1002094 21655083 10.1371/journal.pgen.1002094 1:CAS:528:DC%2BC3MXntlemurs%3D
10. Y Kim FP Lach R Desetty H Hanenberg AD Auerbach A Smogorzewska 2011 Mutations of the SLX4 gene in Fanconi anemia Nat Genet 43 2 142 146 21240275 10.1038/ng.750 1:CAS:528:DC%2BC3MXmsFCntw%3D%3D
11. C Stoepker K Hain B Schuster Y Hilhorst-Hofstee MA Rooimans J Steltenpool AB Oostra K Eirich ET Korthof AW Nieuwint NG Jaspers T Bettecken H Joenje D Schindler J Rouse JP de Winter 2011 SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype Nat Genet 43 2 138 141 21240277 10.1038/ng.751 1:CAS:528:DC%2BC3MXmsFCquw%3D%3D
12. KE Cybulski NG Howlett 2011 FANCP/SLX4: a Swiss army knife of DNA interstrand crosslink repair Cell Cycle 10 1757 1763 21527828 10.4161/cc.10.11.15818
13. NG Howlett T Taniguchi S Olson B Cox Q Waisfisz C De Die-Smulders N Persky M Grompe H Joenje G Pals H Ikeda EA Fox AD D'Andrea 2002 Biallelic inactivation of BRCA2 in Fanconi anemia Science 297 606 609 12065746 10.1126/science.1073834 1:CAS:528:DC%2BD38XlslWrs7k%3D (Pubitemid 34815345)
14. N Rahman S Seal D Thompson P Kelly A Renwick A Elliott S Reid K Spanova R Barfoot T Chagtai H Jayatilake L McGuffog S Hanks DG Evans D Eccles Breast Cancer Susceptibility Collaboration (UK) DF Easton MR Stratton 2007 PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene Nat Genet 39 2 165 167 17200668 10.1038/ng1959 1:CAS:528:DC%2BD2sXpvFeqsw%3D%3D (Pubitemid 46184346)
15. S Seal D Thompson A Renwick A Elliott P Kelly R Barfoot T Chagtai H Jayatilake M Ahmed K Spanova B North L McGuffog DG Evans D Eccles Breast Cancer Susceptibility Collaboration (UK) DF Easton MR Stratton N Rahman 2006 Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles Nat Genet 38 1239 1241 17033622 10.1038/ng1902 1:CAS:528:DC%2BD28XhtFeisbjJ (Pubitemid 44646283)
16. A Meindl H Hellebrand C Wiek V Erven B Wappenschmidt D Niederacher M Freund P Lichtner L Hartmann H Schaal J Ramser E Honisch, et al. 2010 Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene Nat Genet 42 410 414 20400964 10.1038/ng.569 1:CAS:528:DC%2BC3cXkvVCjtbo%3D
17. J Backe S Hofferbert B Skawran T Dörk M Stuhrmann JH Karstens M Untch A Meindl R Burgemeister J Chang-Claude BHF Weber 1999 Frequency of BRCA1 mutation 5382insC in German breast cancer patients Gynecol Oncol 72 402 406 10053113 10.1006/gyno.1998.5270 1:CAS:528:DyaK1MXhsVegsbc%3D (Pubitemid 29118199)
18. T Dörk R Bendix M Bremer D Rades K Klöpper M Nicke B Skawran A Hector P Yamini D Steinmann S Weise M Stuhrmann JH Karstens 2001 Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients Cancer Res 61 7608 7615 11606401 (Pubitemid 32995055)
19. The CHEK2 Breast Cancer Case-Control Consortium 2004 CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10, 860 breast cancer cases and 9, 065 controls from 10 studies Am J Hum Genet 74 1175 1182 10.1086/421251 (Pubitemid 38669316)
20. N Bogdanova S Feshchenko C Cybulski T Dörk 2007 CHEK2 mutation and hereditary breast cancer J Clin Oncol 95 e26 10.1200/JCO.2007.11.4223
21. The Breast Cancer Association Consortium 2006 Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium J Natl Cancer Inst 98 1382 1396 10.1093/jnci/djj374 (Pubitemid 44530715)
22. A Cox AM Dunning M Garcia-Closas S Balasubramanian MWR Reed KA Pooley S Scollen BAJ Ponder S Chanock J Lissowska L Brinton MC Southey, et al. 2007 A common coding variant in CASP8 is associated with breast cancer risk Nat Genet 39 352 358 17293864 10.1038/ng1981 1:CAS:528:DC%2BD2sXitVOktrY%3D (Pubitemid 46328496)
23. DF Easton KA Pooley AM Dunning PDP Pharoah D Thompson DG Ballinger JP Struewing J Morrison H Field R Luben N Wareham S Ahmed, et al. 2007 A genome-wide association study identifies breast cancer susceptibility loci Nature 447 1087 1093 17529967 10.1038/nature05887 1:CAS:528:DC%2BD2sXmvFKmurc%3D (Pubitemid 47014426)
24. S Ahmed G Thomas M Ghoussaini CS Healey MK Humphreys R Platte J Morrison M Maranian K Pooley R Luben D Eccles DG Evans, et al. 2009 Novel breast cancer susceptibility loci on 3p24 and 17q23.2 Nat Genet 41 5 585 590 19330027 10.1038/ng.354 1:CAS:528:DC%2BD1MXjsl2gu7c%3D
25. MK Schmidt J Tommiska A Broeks FE van Leeuwen LJ Van't Veer PD Pharoah DF Easton M Shah M Humphreys T Dörk SA Reincke R Fagerholm C Blomqvist H Nevanlinna 2009 Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients Breast Cancer Res 11 R89 20021639 10.1186/bcr2460
26. WY Lin NJ Camp LA Cannon-Albright K Allen-Brady S Balasubramanian MW Reed JL Hopper C Apicella GG Giles MC Southey RL Milne JI Arias-Pérez, et al. 2011 A role for XRCC2 gene polymorphisms in breast cancer risk and survival J Med Genet 48 477 484 21632523 10.1136/jmedgenet-2011-100018 1:CAS:528: DC%2BC3MXhtVaksLnJ
27. N Bogdanova N Enen-Dubrowinskaja S Festchenko S Lazijuk YI Rogov O Dammann M Bremer JH Karstens C Sohn T Dörk 2005 Association of two mutations in the CHEK2 gene with breast cancer Int J Cancer 116 263 266 15810020 10.1002/ijc.21022 1:CAS:528:DC%2BD2MXmtVaqt7k%3D (Pubitemid 40967263)
28. N Bogdanova S Feshchenko P Schürmann R Waltes B Wieland P Hillemanns YI Rogov O Dammann M Bremer JH Karstens C Sohn R Varon T Dörk 2008 Nijmegen breakage syndrome mutations and risk of breast cancer Int J Cancer 122 4 802 806 17957789 10.1002/ijc.23168 1:CAS:528:DC%2BD1cXhsFShs7w%3D
29. N Bogdanova P Schürmann R Waltes S Feshchenko IV Zalutsky M Bremer T Dörk 2008 NBS1 variant I171V and breast cancer risk Breast Cancer Res Treat 112 75 79 18049891 10.1007/s10549-007-9820-4 1:CAS:528:DC%2BD1cXhtFOjt77K
30. N Bogdanova C Cybulski M Bermisheva I Datsyuk P Yamini P Hillemanns NN Antonenkova E Khusnutdinova J Lubinski T Dörk 2009 A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer Breast Cancer Res Treat 118 1 207 211 18807267 10.1007/s10549-008-0189-9 1:CAS:528: DC%2BD1MXht1GmtbfP
31. N Bogdanova NN Antonenkova YI Rogov JH Karstens P Hillemanns T Dörk 2010 High frequency and allele-specific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from Belarus Clin Genet 78 364 372 20569256 10.1111/j.1399-0004.2010.01473.x 1:CAS:528:DC%2BC3cXhtlSgsLfF
32. PC Ng S Henikoff 2002 Accounting for human polymorphisms predicted to affect protein function Genome Res 12 436 446 11875032 10.1101/gr.212802 1:CAS:528:DC%2BD38XitFSltLg%3D (Pubitemid 34233019)
33. IA Adzhubei S Schmidt L Peshkin VE Ramensky A Gerasimova P Bork AS Kondrashov SR Sunyaev 2010 A method and server for predicting damaging missense mutations Nat Methods 7 4 248 249 20354512 10.1038/nmeth0410-248 1:CAS:528:DC%2BC3cXjvFKqu78%3D
34. AD D'Andrea 2010 Susceptibility pathways in Fanconi's anemia and breast cancer New Engl J Med 362 1909 1919 20484397 10.1056/NEJMra0809889
35. E Levy-Lahad 2010 Fanconi anemia and breast cancer susceptibility meet again Nat Genet 42 5 368 369 20428093 10.1038/ng0510-368 1:CAS:528: DC%2BC3cXlt1OlsL0%3D
36. PJ Stogios GS Downs JJS Jauhal SK Nandra GG Prive 2005 Sequence and structural analysis of BTB domain proteins Genome Biol 8 R82 10.1186/gb-2005-6-10-r82